Evidence map›Paper›PMID 37274960›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2023

Treatment of Early Glottic cancer with Transoral Laser Microsurgery: An Australian Experience.

Navid Ahmadi, Danielle Stone, Murray Stokan, Hedley Coleman, Gillian Heller, Mark Smith, Faruque Riffat, Akshay Kudpaje, Michael Veness, Carsten E Palme

Open access · greenAbstract read
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Prognostic significance of surgical margins in laryngeal cancer treated by transoral laser microsurgery: a systematic review and meta-analysis.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Navid AhmadiDepartment of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW Australia.ORCID 0000-0002-4338-8741
Danielle StoneCrown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Murray StokanDepartment of Anaesthetics, Westmead Hospital, Sydney, NSW Australia.
Hedley ColemanCrown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Gillian HellerNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW Australia.
Mark SmithDepartment of ENT, Westmead Hospital, Sydney, NSW Australia.
Faruque RiffatDepartment of ENT, Westmead Hospital, Sydney, NSW Australia.
Akshay KudpajeCrown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Michael VenessCrown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Carsten E PalmeDepartment of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW Australia.
Westmead Hospital · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Early laryngeal carcinomas may be treated by transoral laser microsurgery (TLM) or external beam radiotherapy. We review our experience of surgical treatment of laryngeal pre-malignant and malignant lesions over the past 15 years in a high-volume head neck unit. Methods: A review of a prospective patient database of patients with laryngeal SCC, who were treated with CO Results: 83 patients with a mean age of 67.7 (SD: 10.6) years underwent primary curative TLM for T1a/b SCC. 5-year overall survival was 93.2% (95%CI 86.9-100%), disease free survival was 86.0% (95%CI 78.1-94.6%), locoregional control was 91.2% (95%CI: 85.1-97.7%) and larynx preservation rate of 95.1% at 5 years. Conclusion: TLM is an excellent treatment modality for T1 early glottic SCC, with excellent locoregional control and disease-free survival. It is minimally invasive, outpatient-based, and cost-effective procedure preserving upper aerodigestive tract dysfunction for all activities of daily living.

Indexed as

Carcinoma, Squamous cellLaryngeal neoplasmsLaryngoscopyLaser therapyRadiotherapySurvival analysis

Identifiers

PMID37274960
PMCPMC10235397
OpenAlexW4313443919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.